Literature DB >> 25833061

Identification of Underlying Causes of Spontaneous Submacular Hemorrhage by Indocyanine Green Angiography.

Hyesun Kim1, Sung Chul Lee, Sang Myung Kim, Ji Hwan Lee, Hyoung Jun Koh, Sung Soo Kim, Suk Ho Byeon, Min Kim, Christopher Seungkyu Lee.   

Abstract

PURPOSE: To investigate the causes of acute spontaneous submacular hemorrhage with indocyanine green angiography (ICGA).
METHODS: Retrospective observation case series. A total of 51 eyes from 51 patients with newly developed spontaneous submacular hemorrhage were enrolled. Best-corrected visual acuity (BCVA), fundus photography, fluorescein angiography, spectral domain optical coherence tomography (OCT), and ICGA at baseline were analyzed. The extent of hemorrhage using fundus photography, height of hemorrhage, and central foveal thickness measured by OCT was analyzed to compare the diagnostic and nondiagnostic groups.
RESULTS: The mean logarithm of the minimum angle of resolution (logMAR) BCVA at presentation was 1.21 ± 0.74 (Snellen equivalent, 20/324); the mean follow-up period was 23.9 ± 23.9 months. The cause of submacular hemorrhage was diagnosed in 43 of 51 eyes (84.3%) based on ICGA at presentation. The initial diagnoses were correct in 93% of eyes. In 3 cases, the initial diagnosis of age-related macular degeneration (AMD) was changed to polypoidal choroidal vasculopathy (PCV) based on follow-up ICGA. The central foveal thickness was significantly greater in the nondiagnostic group (1,102.4 vs. 666.7 μm, respectively; p = 0.008). The most common cause of submacular hemorrhage was neovascular AMD (52.9%), followed by PCV (37.3%), macroaneurysm (5.9%), and lacquer crack (3.9%). The mean final visual acuity was generally worse in patients with submacular hemorrhage with typical AMD (visual acuity 20/618) or PCV (visual acuity 20/240) compared to that in patients with retinal macroaneurysm (visual acuity 20/100) or lacquer crack (visual acuity 20/72).
CONCLUSIONS: ICGA at initial presentation helps identify causes of submacular hemorrhage, allowing differential treatment approaches that may improve outcomes and safety.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25833061     DOI: 10.1159/000380830

Source DB:  PubMed          Journal:  Ophthalmologica        ISSN: 0030-3755            Impact factor:   3.250


  3 in total

Review 1.  Polypoidal choroidal vasculopathy: An update on current management and review of literature.

Authors:  Amit Harishchandra Palkar; Vikas Khetan
Journal:  Taiwan J Ophthalmol       Date:  2019 Apr-Jun

2.  Outcomes of combined treatments in patients with retinal arterial macroaneurysm.

Authors:  Chenghu Wang; Guofan Cao; Xiangzhong Xu; Jian Wang; Shu Zhang
Journal:  Indian J Ophthalmol       Date:  2021-12       Impact factor: 1.848

3.  One-Year Outcome of Intravitreal Tissue Plasminogen Activator, Ranibizumab, and Gas Injections for Submacular Hemorrhage in Polypoidal Choroidal Vasculopathy.

Authors:  Yorihisa Kitagawa; Hiroyuki Shimada; Ryusaburo Mori; Koji Tanaka; Yu Wakatsuki; Hajime Onoe; Hiroyuki Kaneko; Yumiko Machida; Hiroyuki Nakashizuka
Journal:  J Clin Med       Date:  2022-04-13       Impact factor: 4.964

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.